BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

424 related articles for article (PubMed ID: 26453853)

  • 1. Carboxymethyl chitosan-mediated synthesis of hyaluronic acid-targeted graphene oxide for cancer drug delivery.
    Yang H; Bremner DH; Tao L; Li H; Hu J; Zhu L
    Carbohydr Polym; 2016 Jan; 135():72-8. PubMed ID: 26453853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyaluronic acid-modified multiwalled carbon nanotubes for targeted delivery of doxorubicin into cancer cells.
    Cao X; Tao L; Wen S; Hou W; Shi X
    Carbohydr Res; 2015 Mar; 405():70-7. PubMed ID: 25500334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sodium alginate conjugated graphene oxide as a new carrier for drug delivery system.
    Fan L; Ge H; Zou S; Xiao Y; Wen H; Li Y; Feng H; Nie M
    Int J Biol Macromol; 2016 Dec; 93(Pt A):582-590. PubMed ID: 27616692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lactobionic acid and carboxymethyl chitosan functionalized graphene oxide nanocomposites as targeted anticancer drug delivery systems.
    Pan Q; Lv Y; Williams GR; Tao L; Yang H; Li H; Zhu L
    Carbohydr Polym; 2016 Oct; 151():812-820. PubMed ID: 27474628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyaluronic acid-decorated graphene oxide nanohybrids as nanocarriers for targeted and pH-responsive anticancer drug delivery.
    Song E; Han W; Li C; Cheng D; Li L; Liu L; Zhu G; Song Y; Tan W
    ACS Appl Mater Interfaces; 2014 Aug; 6(15):11882-90. PubMed ID: 25000539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted delivery and controlled release of doxorubicin into cancer cells using a multifunctional graphene oxide.
    Lv Y; Tao L; Annie Bligh SW; Yang H; Pan Q; Zhu L
    Mater Sci Eng C Mater Biol Appl; 2016 Feb; 59():652-660. PubMed ID: 26652419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functionalized Graphene Oxide with Hepatocyte Targeting as Anti-Tumor Drug and Gene Intracellular Transporters.
    Cao X; Zheng S; Zhang S; Wang Y; Yang X; Duan H; Huang Y; Chen Y
    J Nanosci Nanotechnol; 2015 Mar; 15(3):2052-9. PubMed ID: 26413620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design and evaluation of galactosylated chitosan/graphene oxide nanoparticles as a drug delivery system.
    Wang C; Zhang Z; Chen B; Gu L; Li Y; Yu S
    J Colloid Interface Sci; 2018 Apr; 516():332-341. PubMed ID: 29408121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyaluronic acid and Arg-Gly-Asp peptide modified Graphene oxide with dual receptor-targeting function for cancer therapy.
    Guo Y; Xu H; Li Y; Wu F; Li Y; Bao Y; Yan X; Huang Z; Xu P
    J Biomater Appl; 2017 Jul; 32(1):54-65. PubMed ID: 28554233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel carboxymethyl chitosan-graphene oxide hybrid particles for drug delivery.
    Shi Y; Xiong Z; Lu X; Yan X; Cai X; Xue W
    J Mater Sci Mater Med; 2016 Nov; 27(11):169. PubMed ID: 27709459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cholesteryl hyaluronic acid-coated, reduced graphene oxide nanosheets for anti-cancer drug delivery.
    Miao W; Shim G; Kang CM; Lee S; Choe YS; Choi HG; Oh YK
    Biomaterials; 2013 Dec; 34(37):9638-47. PubMed ID: 24016852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Remote controlled drug release from multi-functional Fe
    Li S; Xiao L; Deng H; Shi X; Cao Q
    Colloids Surf B Biointerfaces; 2017 Mar; 151():354-362. PubMed ID: 28043052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. pH-Controlled drug delivery with hybrid aerogel of chitosan, carboxymethyl cellulose and graphene oxide as the carrier.
    Wang R; Shou D; Lv O; Kong Y; Deng L; Shen J
    Int J Biol Macromol; 2017 Oct; 103():248-253. PubMed ID: 28526342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Photoresponsive fluorescent reduced graphene oxide by spiropyran conjugated hyaluronic acid for in vivo imaging and target delivery.
    Nahain AA; Lee JE; Jeong JH; Park SY
    Biomacromolecules; 2013 Nov; 14(11):4082-90. PubMed ID: 24106989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Controlled release of doxorubicin from graphene oxide based charge-reversal nanocarrier.
    Zhou T; Zhou X; Xing D
    Biomaterials; 2014 Apr; 35(13):4185-94. PubMed ID: 24513318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Facile preparation of antibacterial chitosan/graphene oxide-Ag bio-nanocomposite hydrogel beads for controlled release of doxorubicin.
    Rasoulzadehzali M; Namazi H
    Int J Biol Macromol; 2018 Sep; 116():54-63. PubMed ID: 29705108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chitosan/o-carboxymethyl chitosan nanoparticles for efficient and safe oral anticancer drug delivery: in vitro and in vivo evaluation.
    Feng C; Wang Z; Jiang C; Kong M; Zhou X; Li Y; Cheng X; Chen X
    Int J Pharm; 2013 Nov; 457(1):158-67. PubMed ID: 24029170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PEGylated doxorubicin cloaked nano-graphene oxide for dual-responsive photochemical therapy.
    Wang L; Yu D; Dai R; Fu D; Li W; Guo Z; Cui C; Xu J; Shen S; Ma K
    Int J Pharm; 2019 Feb; 557():66-73. PubMed ID: 30580088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chitosan-grafted-poly(methacrylic acid)/graphene oxide nanocomposite as a pH-responsive de novo cancer chemotherapy nanosystem.
    Abbasian M; Roudi MM; Mahmoodzadeh F; Eskandani M; Jaymand M
    Int J Biol Macromol; 2018 Oct; 118(Pt B):1871-1879. PubMed ID: 30017982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Graphene oxide based functionalized chitosan polyelectrolyte nanocomposite for targeted and pH responsive drug delivery.
    Anirudhan TS; Chithra Sekhar V; Athira VS
    Int J Biol Macromol; 2020 May; 150():468-479. PubMed ID: 32044367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.